Palvella Therapeutics (PVLA) Cash from Financing Activities (2013 - 2026)
Palvella Therapeutics (PVLA) reported Cash from Financing Activities of $214.7 million for Q1 2026, up 17964.48% year-over-year from N/an in Q1 2025, and up 438326.53% on a QoQ basis from -$49000.0 in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Cash from Financing Activities data on file, last reported at $214.7 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 17964.48% year-over-year to $214.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215.3 million (up 150.65% YoY) and the FY2025 annual result came in at -$660000.0, down 100.76% from the prior year.
- Cash from Financing Activities improved to $214.7 million in Q1 2026 per PVLA's latest filing, from -$49000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $214.7 million in Q1 2026 and bottomed at -$14.8 million in Q4 2023.
- The 5-year median for Cash from Financing Activities is $315500.0 (2022), against an average of $22.4 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities tumbled 15993.55%; it then jumped 17964.48% in 2026.
- Tracing PVLA's Cash from Financing Activities over 5 years: stood at $93000.0 in 2022, then plunged by 15993.55% to -$14.8 million in 2023, then jumped by 605.95% to $74.8 million in 2024, then plunged by 100.07% to -$49000.0 in 2025, then soared by 438326.53% to $214.7 million in 2026.
- Per Business Quant, the three latest PVLA Cash from Financing Activities figures stand at $214.7 million (Q1 2026), -$49000.0 (Q4 2025), and $242000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 214.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214.73 Mn |
| Mar 31, 2026 | 214.73 Mn |
| Dec 31, 2025 | -49,000.00 |
| Dec 31, 2025 | -49,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | -1.20 Mn |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | 74.79 Mn |
| Dec 31, 2024 | 74.79 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Dec 31, 2023 | -14.78 Mn |
| Dec 31, 2023 | -14.78 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Dec 31, 2022 | 93,000.00 |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 281,000.00 |
| Jun 30, 2022 | 281,000.00 |
| Mar 31, 2022 | 6.56 Mn |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 21.92 Mn |
| Sep 30, 2021 | 21.92 Mn |
| Jun 30, 2021 | 22.62 Mn |
| Jun 30, 2021 | 22.62 Mn |
| Mar 31, 2021 | 9.69 Mn |
| Mar 31, 2021 | 9.69 Mn |
| Dec 31, 2020 | 75,000.00 |
| Dec 31, 2020 | 75,000.00 |
| Sep 30, 2020 | 9.62 Mn |
| Sep 30, 2020 | 9.62 Mn |
| Jun 30, 2020 | 416,000.00 |
| Jun 30, 2020 | 416,000.00 |
| Dec 31, 2019 | 31.67 Mn |
| Dec 31, 2019 | 31.67 Mn |
| Sep 30, 2019 | 221,000.00 |
| Sep 30, 2019 | 221,000.00 |
| Jun 30, 2019 | 280,000.00 |
| Jun 30, 2019 | 280,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Sep 30, 2018 | 276,000.00 |
| Sep 30, 2018 | 276,000.00 |
| Jun 30, 2018 | 69,000.00 |
| Jun 30, 2018 | 69,000.00 |
| Mar 31, 2018 | 48.16 Mn |
| Mar 31, 2018 | 48.16 Mn |
| Dec 31, 2017 | 597,000.00 |
| Dec 31, 2017 | 597,000.00 |
| Sep 30, 2017 | 2.03 Mn |
| Sep 30, 2017 | 2.03 Mn |
| Jun 30, 2017 | 1.47 Mn |
| Jun 30, 2017 | 1.47 Mn |
| Dec 31, 2016 | -21.00 |
| Dec 31, 2016 | -21.00 |
| Sep 30, 2016 | -59,651.00 |
| Sep 30, 2016 | -59,651.00 |
| Jun 30, 2016 | 15.28 Mn |
| Jun 30, 2016 | 15.28 Mn |
| Dec 31, 2015 | 10,000.00 |
| Dec 31, 2015 | 10,000.00 |
| Sep 30, 2015 | 25.78 Mn |
| Sep 30, 2015 | 25.78 Mn |
| Jun 30, 2015 | -43,365.00 |
| Jun 30, 2015 | -43,365.00 |
| Mar 31, 2015 | -1.13 Mn |
| Mar 31, 2015 | -1.13 Mn |
| Sep 30, 2014 | 3,000.00 |
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 1.22 Mn |
| Jun 30, 2014 | 1.22 Mn |
| Mar 31, 2014 | 400.00 |
| Mar 31, 2014 | 400.00 |
| Dec 31, 2013 | 1,600.00 |
| Dec 31, 2013 | 1,600.00 |
| Jun 30, 2013 | 5,474.00 |
| Jun 30, 2013 | 5,474.00 |